You have 9 free searches left this month | for more free features.

dopamine agonist

Showing 1 - 25 of 2,532

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pituitary Tumors, Adenoma Trial in Oslo, Trondheim, Gøteborg (cabergoline)

Recruiting
  • Pituitary Neoplasms
  • Adenoma
  • Oslo, Norway
  • +2 more
Jan 19, 2023

Addiction Trial in Berkeley, San Francisco (Tolcapone, Placebo, Bromocriptine)

Withdrawn
  • Addiction
  • Berkeley, California
  • +1 more
Nov 12, 2021

Hyperprolactinemia, Prolactinoma Trial in New York (Ropinirole)

Completed
  • Hyperprolactinemia
  • Prolactinoma
  • New York, New York
    Columbia University Medical Center
Jul 9, 2021

Restless Legs Syndrome Trial in Beijing (Pramipexole, )

Terminated
  • Restless Legs Syndrome
  • Beijing, China
    Peking University First Hospital
Nov 28, 2021

Impulse Control Disorder Trial in Korea, Republic of (Levodopa/Carbidopa(200mg/50mg), Dopaminergic Agonists)

Completed
  • Impulse Control Disorder
  • Anyang, Korea, Republic of
  • +4 more
Mar 9, 2021

Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

Recruiting
  • Diffuse Midline Glioma (DMG)
  • +7 more
  • ONC206
  • Standard of Care Radiation Therapy
  • San Francisco, California
  • +2 more
Sep 13, 2022

Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia

Withdrawn
  • Schizophrenia
  • NPA radiotracer
  • +2 more
  • New York, New York
    NYU Langone Health
May 27, 2020

Endometriosis Trial in Boston (Cabergoline, Norethindrone acetate)

Completed
  • Endometriosis
  • Boston, Massachusetts
    Children's Hospital Boston
Jan 27, 2020

Emotions, Motivation, Reward Trial in Oxford (Pramipexole, Placebo)

Completed
  • Emotions
  • +3 more
  • Oxford, Oxfordshire, United Kingdom
    Dept of Psychiatry, University of Oxford
Mar 23, 2020

Parkinson Disease Trial in Nashville (Pramipexole, Placebo)

Recruiting
  • Parkinson Disease
  • Nashville, Tennessee
    Vanderbilt University Medical Center
May 2, 2022

Lactation Suppressed Trial in Stanford (Cabergoline 1 MG, Placebo)

Not yet recruiting
  • Lactation Suppressed
  • Cabergoline 1 MG
  • Placebo
  • Stanford, California
    Stanford University
Sep 1, 2023

Overweight and Obesity, Eating Behavior Trial in Chapel Hill (Placebo, Bromocriptine-QR)

Completed
  • Overweight and Obesity
  • Eating Behavior
  • Chapel Hill, North Carolina
    University of North Carolina, Chapel Hill
Aug 12, 2022

Vigor and the LDR in Parkinson Disease

Recruiting
  • Parkinson Disease
  • carbidopa/levodopa, as prescribed by treating physician
  • Ann Arbor, Michigan
    University of Michigan
Dec 1, 2022

Health Trial in Edmonton (Dopamine, Metoclopramide, Placebos)

Recruiting
  • Health
  • Edmonton, Alberta, Canada
    Clinical Physiology Research Laboratory
Apr 6, 2022

Fibromyalgia, Pain, Chronic, Chronic Pain, Widespread Trial in Zürich (Low dose naltrexone, Placebo, Bromocriptine Mesylate

Recruiting
  • Fibromyalgia
  • +2 more
  • Low dose naltrexone
  • +3 more
  • Zürich, Switzerland
    Balgrist Campus
Feb 20, 2022

DTx Algorithms for Personalized Parkinson's Disease Treatment

Not yet recruiting
  • Parkinson Disease
  • Smartwatch Garmin Vivosmart [wearable sensor]
  • +2 more
  • Roma, Italy
  • +2 more
Jun 13, 2023

Parkinson Disease Trial in Lille (A-dopamine, optimized oral treatment)

Recruiting
  • Parkinson Disease
  • Lille, France
    Hopital Roger Salengro, CHU Lille
Oct 11, 2022

Healthy Trial in Zürich (Psilocybin, 3,4 Methylenedioxymethamphetamine, Methylphenidate)

Recruiting
  • Healthy
  • Zürich, Switzerland
    Psychiatrische Universitätsklinik Zürich
Oct 3, 2023

Parkinson Disease Trial in France (drug, behavioral, procedure)

Recruiting
  • Parkinson Disease
  • Active drug: pimavanserin 17mg (2 strength tablets)
  • +9 more
  • Besançon, France
  • +15 more
Jan 20, 2022

Lactation Suppressed Trial in Stanford (Cabergoline 1 MG, Placebo)

Active, not recruiting
  • Lactation Suppressed
  • Cabergoline 1 MG
  • Placebo
  • Stanford, California
    Stanford University
Jul 7, 2022

Anorexia Nervosa Trial in San Diego (amisulpride, bromocriptine)

Recruiting
  • Anorexia Nervosa
  • San Diego, California
    University of California San Diego
Sep 2, 2021

Schizophrenia, Glucose Intolerance Trial in Pittsburgh (Bromocriptine)

Not yet recruiting
  • Schizophrenia
  • Glucose Intolerance
  • Pittsburgh, Pennsylvania
    VA Pittsburgh Healthcare System
Oct 11, 2022

Impulsivity in Idiopathic REM Sleep Behavior Disorder

Recruiting
  • Parkinson Disease
  • No intervention
  • Hong Kong, Hong Kong
    The Chinese University of Hong Kong
Aug 22, 2022

Frontotemporal Dementia, Dementia, Aphasia, Primary Progressive Trial in Brescia, Rome (Rotigotine 4Mg/24Hrs Patch, Rotigotine

Active, not recruiting
  • Frontotemporal Dementia
  • +19 more
  • Rotigotine 4Mg/24Hrs Patch
  • +2 more
  • Brescia, Italy
  • +2 more
Jul 7, 2022

Parkinson Disease Trial (Conventional medication, Chinese herbal medicine treatment)

Not yet recruiting
  • Parkinson Disease
  • Conventional medication
  • Chinese herbal medicine treatment
  • (no location specified)
Aug 10, 2021